HAYWARD, Calif.--(BUSINESS WIRE)--Rondo Therapeutics, a clinical-stage biopharmaceutical company pioneering next-generation T-cell engaging bispecific antibodies for solid tumors, today announced that ...

Rondo Therapeutics Doses First Patient in Phase 1 Trial of RNDO-564, a First-in-Class Co-Stimulatory Bispecific Antibody Targeting Nectin-4 in Advanced Solid Tumors Novel CD28 x Nectin-4 bispecific ...

A watercolor painting of tulips in a glass jar is among works on view at Art Heals – Patient Art Exhibit and Reception. (Youngmi An photo) For the past 26 years, patients and caregivers have come ...

Two data companies and four health care groups in Maine are facing a class-action lawsuit about how patient records are handled. “I will not allow Donald Trump to silence me”: Army combat veteran ...

PARKVILLE, Mo. (KCTV) - A diagnosis like Parkinson’s disease can be disheartening and make one lose confidence. But at the Platt County Y, participants in Pedal for Parkinson’s are gaining back that ...

Bayhealth Medical has reached a settlement in a class-action lawsuit over a breach of patients’ personal data in 2024, according to court filings. The hospital system, one of the three primary health ...

In this Q&A, Mineralys CEO Jon Congleton discusses how targeting aldosterone could reshape hypertension treatment. Aldosterone synthase inhibitors (ASIs) are drawing a lot of attention. What first ...

DONGGUAN, China, Aug 5, 2025 /PRNewswire/ -- Fapon Biopharma, a biotech in developing therapeutic antibodies and fusion proteins, is delighted to announce the completion of the first patient ...

The Yale School of Medicine is offering some of their patients with chronic health conditions culinary classes to learn new skills to change their diet. NBC News' Dr. Akshay Syal spoke with some of ...

Improv comedy classes are part of the training medical residents at Minnesota's Mayo Clinic receive. It's an effort to help doctors learn early how to improve relationships with patients. Some doctors ...